Traditional Chinese medicine composition for preventing or treating tumor complication constipation

Abstract

The invention provides a traditional Chinese medicine composition and a traditional Chinese medicine preparation for preventing or treating tumor complication - constipation. The traditional Chinese medicine composition are composed of following raw material medicines comprising, by weight, 20-40 parts of raw rhubarb, 5-15 parts of cortex magnoliae officinalis, 5-15 parts of fructus aurantii immaturus, 5-15 parts of rhizoma sparganic, 5-15 parts of flos caryophyllata and 0.5-1.5 parts of menthol. Through the traditional Chinese medicine composition and the traditional Chinese medicine preparation, relative constipation syndromes caused by tumor complications can be effectively prevented or treated. The composition and the preparation are direct in effects, are safe to use, are noninvasive and free of pains, are easy to use, are convenient to popularize, is simple in formula and low in cost, can ensure a good compliance of patients, can alleviate pain in tumor patients at a certain degree, can improve life quality of the patients and meanwhile can reduce economic burden of the patients.

Description

technical field [0001] The invention relates to the field of traditional Chinese medicine, in particular to a traditional Chinese medicine composition for preventing or treating constipation caused by tumors and its application. Background technique [0002] About 80% of patients are diagnosed with malignant tumors in the middle and advanced stages, and the main cause of suffering, disability, and death of patients is tumor complications. The basic contents of tumor complications are: malignant tumors are directly or indirectly caused during the occurrence and development of malignant tumors; iatrogenic problems caused by surgery, radiotherapy and chemotherapy (including diagnosis). Whether certain complications are discovered in time and handled properly determines whether the tumor can be cured or whether it can be further treated to obtain long-term survival chances. The harm is self-evident. [0003] Constipation is a common symptom in patients with malignant tumors, wh...

AI Technical Summary

Problems solved by technology

Traditional expansive laxatives, stimulant laxatives, lubricating laxatives, and rectal laxatives have defects such as inaccurate curative effect, low specificity, toxicity of some ingredients, many adverse reactions that are difficult to tolerate, and limited treatment range. little research

Currently, the laxatives that are widely accepted clinically and actively developed mainly focus on gastrointestinal motility agents (such as tegaserod), osmotic laxatives (such as polyethylene glycol 4000, polyethylene glycol 3350), and some traditional laxatives. Newer pure natural medicines based on catharsis medicines, but these medicines are expensive, and patients with constipation are dependent on these medicines. If they are used for too long, the patient's autonomous defecation function will be further weakened and constipation will be further aggravated

Images